Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The analgesic effect of Nepafenac 0.1% Ophthalmic Drops on ocular pain related to
intravitreal injections will be evaluated.
Pain perception will be assessed by the Short Form of the McGill Pain Questionnaire.